 |
INDIA IVD (INSTRUMENTS & REAGENTS) MARKET, SHARE, REGISTRATION, REGULATIONS & CLASSIFICATION OF IVD AND KEY PLAYERS ANALYSIS - FORECAST TO 2025
India In-Vitro Diagnostics (IVD) market is likely to exceed US$ 1.8 Billion mark by 2025. The IVD industry in India has been witnessing immense progress. Major technological advancements and higher efficiency systems have taken the sector to new heights. Advanced cutting-edge technologies are being used to understand disease prognosis, thereby strengthening the sophistication level of the participants in the sector. The growing demand for personalized medicines, innovations in diagnostic techniques, increasing preference for point of-care testing among the general population, a growing geriatric population base and increase in disposable incomes is driving the growth of the IVD sector in India.
In India, the emerging trend of corporate players establishing diagnostic centers in small towns and rural areas tends to provide opportunities for the import of automated systems and reagents. For instance, Metropolis Healthcare has announced plans to add 800 collection centers, and 10 labs by end of Fiscal Year 2019. Moreover, global IVD companies are expanding their operational footprint in India which presents a growing market for their products like ready-to-use test kits equipped with features like high specificity and acute diagnostic analysis. Thus, IVD market in India is growing at an extraordinary pace and the country has the potential to emerge as a global manufacturing hub in the medical devices space.
India IVD Market Segment Analysis
• Biochemistry is the leading segment in India IVD market.
• Immunochemistry holds the 2nd position in India IVD market being followed by Hematology.
• Microbiology is the fastest growing segment of the Indian IVD market.
• The Indian urinalysis (instruments and reagents) market was in the range of US$ 20 - 25 Million in 2018.
• Molecular diagnostics and Coagulation segments are competing closely with each other to grab maximum share of the pie.
India IVD Market Company Analysis
• Roche captures maximum share of the India IVD market.
• Siemens and Transasia held the 2nd and 3rd position in Indian IVD market.
• TransAsia has a strong presence in small and medium-sized independent diagnostics centers across India.
• Abbott Laboratories, Sysmex Corporation, Thermo Fisher Scientific Inc. and Biomerieux are other top four players in the India IVD market.
• Global IVD companies are expanding their operational footprint in India which presents a growing market for their products.
iGATE RESEARCH report titled “India IVD (Instruments & Reagents) Market, Share, Registration, Regulations & Classification of IVD and Key Players Analysis - Forecast to 2025” provides a comprehensive analysis of the India In-Vitro Diagnostics (IVD) Market.
This 100 Page report with 62 Figures and 4 Tables has been analyzed from 7 View Points:
1) India IVD Market and Forecast (2012 - 2025)
2) India IVD Market Share and Forecast (2012 - 2025)
3) India IVD Market & Forecast – By Segment (2012 - 2025)
4) India IVD Market & Forecast – Key Players Sales Analysis (2015 - 2025)
5) Registration for In Vitro Diagnostic in India
6) Regulatory and Classification of IVD in India
7) India IVD Market - Growth Drivers & Challenges
India IVD (Instruments & Reagents) Market – By Application Segments
1. Biochemistry
2. Immunochemistry
3. Hematology
4. Urinalysis
5. Microbiology
6. Molecular Diagnostics
7. Coagulation
8. Others
India IVD Market & Forecast – Key Players Analysis
1. Roche Diagnostic
2. Siemens
3. Transasia Bio–Medicals Ltd.
4. Abbott Laboratories
5. Sysmex Corporation
6. Thermo Fisher Scientific Inc
7. bioMérieux
8. Others
iGATE Research has released a report on "INDIA IVD (INSTRUMENTS & REAGENTS) MARKET, SHARE, REGISTRATION, REGULATIONS & CLASSIFICATION OF IVD AND KEY PLAYERS ANALYSIS - FORECAST TO 2025"
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=154
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
Контактное лицо: iGATE Research
Компания: iGATE Research
Добавлен: 23:14, 21.10.2019
Количество просмотров: 362
Страна: Россия
| «АЛМИ Партнер» упрощает переход на «АльтерОфис 2025» для компаний, ALMI Partner, 23:07, 05.06.2025, Россия134 |  |
| Компания «АЛМИ Партнер», российский разработчик общесистемного и прикладного программного обеспечения объявляет о старте специальной акции для бизнеса. Корпоративные клиенты, приобретающие лицензии на офисный пакет «АльтерОфис 2025», получат расширенные возможности без дополнительной оплаты за «Альтер+». |
| В России появится услуга страхования рисков импортозамещения ERP, НЦК ИСУ, 23:06, 05.06.2025, Россия123 |  |
| АНО «Национальный центр компетенций по информационным системам управления холдингом», Страховой Дом ВСК и Ассоциация предприятий компьютерных и информационных технологий (АПКИТ) создадут продукты для страхования рисков проектов по импортозамещению ERP. |
| Axenix погрузил студентов ТвГУ в мир 1С ERP, Axenix, 08:28, 02.06.2025, Россия361 |  |
| Студенты Тверского государственного университета познакомились с возможностями ИТ-продуктов «1С» в рамках активностей Центра сертифицированного обучения (ЦСО), открытого консалтинговой технологической компанией Axenix. |
| ГК «НОРД» приняла участие в форуме «Налоги. Бизнес. Право», ГК «НОРД», 08:26, 02.06.2025, Россия339 |
| 29 мая 2025 года в Москве прошёл форум «Налоги. Бизнес. Право» , в котором приняла участие Группа компаний «НОРД» . От компании выступила Татьяна Парфенова , аудитор с 20-летним стажем, представившая доклад на тему «Госконтракты в бизнесе» . |
| ЕДИНЫЙ ЦУПИС – золотой партнер конференции Analyst Days/20, ЕДИНЫЙ ЦУПИС (НКО "Мобильная карта"), 23:43, 01.06.2025, Россия126 |
| 23-24 мая 2025 года в Санкт-Петербурге состоялась 20-я Международная конференция по системному и бизнес-анализу Analyst Days. ЕДИНЫЙ ЦУПИС, финтех-сервис в регулируемой индустрии развлечений, выступил золотым партнером главного события в мире аналитиков. |
|
|
